Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Minimal Disease Activity Sustained in Atopic Dermatitis
February 2026
Most early responders with atopic dermatitis sustain minimal disease activity at one year, with baseline factors predicting long-term control.
Read more
27 Feb 2026
Minimal Disease Activity Sustained in Atopic Dermatitis
Most early responders with atopic dermatitis sustain minimal disease activity at one year, with baseline factors predicting long-term control.
23 Feb 2026
Bimekizumab Sustains 3-Year Benefits in Psoriasis
Three-year BE RADIANT results highlight durable bimekizumab benefits in plaque psoriasis, improving PROs and QoL. Read more.
21 Feb 2026
Silicone Gel Significantly Improves Head and Neck Scar Outcomes
A randomised placebo-controlled study shows silicone gel significantly improves scar quality in head and neck wounds without adverse effects.
19 Feb 2026
Major Depressive Disorder Shares Immune Signature with AD
Major depressive disorder shares a Th2 immune signature with atopic dermatitis, highlighting dupilumab as a potential targeted therapy.
16 Feb 2026
Molecular Diagnostics Improve Hand Dermatoses Diagnosis and QoL
A long-term cohort study shows molecular diagnostics can distinguish hand eczema from psoriasis, improving treatment decisions and patient quality of life.
14 Feb 2026
Stopping Washcloth Use May Reduce Pruritus, Study Suggests
Stopping washcloth use during bathing may significantly reduce chronic itch, according to a new observational dermatology study exploring simple lifestyle changes.
12 Feb 2026
Lifestyle and Mental Health Play Key Role in Adult Acne
A study of nearly 12,000 adults links sedentary behaviour, late sleep and psychological distress to higher adult acne risk, while regular exercise shows protective benefits.
11 Feb 2026
tRNA Fragment Shown to Protect Skin Against Photoageing
New research identifies a tRNA-derived RNA fragment that protects skin from UV-induced photoageing by preserving collagen and stabilising key mRNAs.
Loading posts...
1
2
3
…
46
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View